CZ303241B6 - Krystalické formy pyrimidinového nukleosidového derivátu - Google Patents
Krystalické formy pyrimidinového nukleosidového derivátu Download PDFInfo
- Publication number
- CZ303241B6 CZ303241B6 CZ20032111A CZ20032111A CZ303241B6 CZ 303241 B6 CZ303241 B6 CZ 303241B6 CZ 20032111 A CZ20032111 A CZ 20032111A CZ 20032111 A CZ20032111 A CZ 20032111A CZ 303241 B6 CZ303241 B6 CZ 303241B6
- Authority
- CZ
- Czechia
- Prior art keywords
- crystalline form
- compound
- crystals
- wavelength
- rays
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001033128 | 2001-02-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CZ20032111A3 CZ20032111A3 (cs) | 2003-12-17 |
| CZ303241B6 true CZ303241B6 (cs) | 2012-06-13 |
Family
ID=18896929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CZ20032111A CZ303241B6 (cs) | 2001-02-09 | 2002-02-06 | Krystalické formy pyrimidinového nukleosidového derivátu |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1364959B1 (https=) |
| JP (2) | JP3748536B2 (https=) |
| KR (1) | KR100679904B1 (https=) |
| CN (1) | CN100408591C (https=) |
| AT (1) | ATE361929T1 (https=) |
| AU (1) | AU2002230164B2 (https=) |
| BR (2) | BR0207102A (https=) |
| CA (1) | CA2437994C (https=) |
| CY (1) | CY1106685T1 (https=) |
| CZ (1) | CZ303241B6 (https=) |
| DE (1) | DE60220024T2 (https=) |
| DK (1) | DK1364959T3 (https=) |
| ES (1) | ES2286237T3 (https=) |
| HU (1) | HU229294B1 (https=) |
| IL (2) | IL157216A0 (https=) |
| MX (1) | MXPA03007123A (https=) |
| NZ (1) | NZ527393A (https=) |
| PT (1) | PT1364959E (https=) |
| RU (1) | RU2256666C2 (https=) |
| WO (1) | WO2002064609A1 (https=) |
| ZA (1) | ZA200306121B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2265101B1 (en) | 1999-09-02 | 2012-08-29 | Ibiden Co., Ltd. | Printed circuit board and method of manufacturing printed circuit board |
| US6876554B1 (en) | 1999-09-02 | 2005-04-05 | Ibiden Co., Ltd. | Printing wiring board and method of producing the same and capacitor to be contained in printed wiring board |
| GB0526419D0 (en) * | 2005-12-23 | 2006-02-08 | Cyclacel Ltd | Formulation |
| GB0625283D0 (en) | 2006-12-19 | 2007-01-24 | Cyclacel Ltd | Combination |
| JP5066737B2 (ja) * | 2007-04-06 | 2012-11-07 | 大鵬薬品工業株式会社 | シチジン誘導体を含有する持続静脈内投与用抗腫瘍剤 |
| US8124593B2 (en) | 2007-11-05 | 2012-02-28 | Cyclacel Limited | Methods of treatment using sapacitabine |
| GB0808357D0 (en) * | 2008-05-08 | 2008-06-18 | Cyclacel Ltd | Process |
| NZ589719A (en) | 2008-06-09 | 2012-08-31 | Cyclacel Ltd | Combinations of sapacitabine or cndac with dna methyltransferase inhibitors such as decitabine and procaine |
| HUE046177T2 (hu) | 2011-04-14 | 2020-02-28 | Cyclacel Ltd | Szapacitabin és decitabin kombinációjának adagolási rendje akut mieloid leukémia kezelésére |
| KR102081042B1 (ko) * | 2012-03-15 | 2020-02-26 | 셀젠 카르 엘엘씨 | 상피 성장 인자 수용체 키나제 억제제의 고체 형태 |
| EP3268379B1 (en) | 2015-03-09 | 2023-11-01 | W.R. Grace & CO. - CONN. | Crystalline form of nicotinamide riboside |
| CN112020363A (zh) | 2017-12-22 | 2020-12-01 | 益力舒健康公司 | 烟酰胺核苷氯化物的结晶形式 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0536936A1 (en) * | 1991-09-30 | 1993-04-14 | Sankyo Company Limited | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2559917B2 (ja) * | 1990-06-15 | 1996-12-04 | 三共株式会社 | ピリミジンヌクレオシド誘導体 |
-
2002
- 2002-02-04 JP JP2002026232A patent/JP3748536B2/ja not_active Expired - Lifetime
- 2002-02-06 AU AU2002230164A patent/AU2002230164B2/en not_active Expired
- 2002-02-06 WO PCT/JP2002/000986 patent/WO2002064609A1/ja not_active Ceased
- 2002-02-06 EP EP02711347A patent/EP1364959B1/en not_active Expired - Lifetime
- 2002-02-06 NZ NZ527393A patent/NZ527393A/en not_active IP Right Cessation
- 2002-02-06 DE DE60220024T patent/DE60220024T2/de not_active Expired - Lifetime
- 2002-02-06 AT AT02711347T patent/ATE361929T1/de active
- 2002-02-06 KR KR1020037010308A patent/KR100679904B1/ko not_active Expired - Lifetime
- 2002-02-06 BR BR0207102-9A patent/BR0207102A/pt not_active Application Discontinuation
- 2002-02-06 BR BRPI0207102A patent/BRPI0207102A8/pt unknown
- 2002-02-06 HU HU0303159A patent/HU229294B1/hu unknown
- 2002-02-06 MX MXPA03007123A patent/MXPA03007123A/es active IP Right Grant
- 2002-02-06 DK DK02711347T patent/DK1364959T3/da active
- 2002-02-06 PT PT02711347T patent/PT1364959E/pt unknown
- 2002-02-06 CZ CZ20032111A patent/CZ303241B6/cs not_active IP Right Cessation
- 2002-02-06 CN CNB028079337A patent/CN100408591C/zh not_active Expired - Lifetime
- 2002-02-06 IL IL15721602A patent/IL157216A0/xx active IP Right Grant
- 2002-02-06 CA CA2437994A patent/CA2437994C/en not_active Expired - Lifetime
- 2002-02-06 RU RU2003124648/04A patent/RU2256666C2/ru active
- 2002-02-06 ES ES02711347T patent/ES2286237T3/es not_active Expired - Lifetime
-
2003
- 2003-08-04 IL IL157216A patent/IL157216A/en unknown
- 2003-08-07 ZA ZA2003/06121A patent/ZA200306121B/en unknown
-
2005
- 2005-08-09 JP JP2005230800A patent/JP4356998B2/ja not_active Expired - Lifetime
-
2007
- 2007-07-02 CY CY20071100860T patent/CY1106685T1/el unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0536936A1 (en) * | 1991-09-30 | 1993-04-14 | Sankyo Company Limited | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use |
| JP2569251B2 (ja) * | 1991-09-30 | 1997-01-08 | 三共株式会社 | ピリミジンヌクレオシド誘導体 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2414470C2 (ru) | Кристаллические формы соединения тиазолидиндиона и способ его получения | |
| CN114206878B (zh) | 乌帕替尼的晶型及其制备方法和用途 | |
| CZ303241B6 (cs) | Krystalické formy pyrimidinového nukleosidového derivátu | |
| US6908906B2 (en) | Crystalline forms of pyrimidine nucleoside derivative | |
| US8772488B2 (en) | Crystals of prasugrel hydrobromate | |
| EP3315493B1 (en) | Phenyl amino pyrimidine compound or polymorph of salt thereof | |
| ES3051838T3 (en) | Solid state forms of rucaparib salts | |
| KR100909923B1 (ko) | Ｎ-(2,3-디메틸-5,6,7,8-테트라히드로푸로[2,3-ｂ]퀴놀린-4-일)-2-(2-옥소피롤리딘-1-일)아세트아미드의 다형체 | |
| KR20110024057A (ko) | 신규한 프라수그렐 황산수소염의 결정다형 | |
| KR20260049277A (ko) | 5-((3R,55)-3-아미노-5-트리플루오로메틸-피페리딘-1-일)-퀴놀린-8-카르보니트릴HCl 결정형 A1 | |
| AU2024319768A1 (en) | Crystalline form h1 of 5-((3r,55)-3-amino-5- trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile hemihydrate | |
| WO2020156150A1 (zh) | 泊马度胺前体药物盐的多晶型物 | |
| CN112334473A (zh) | 一种杂芳基并[4,3-c]嘧啶-5-胺类衍生物的晶型及制备方法 | |
| JP2007297332A (ja) | ベンズアミジン誘導体の結晶 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4A | Patent expired |
Effective date: 20220206 |